COVID-19 and substance use disorders: a review of international guidelines for frontline healthcare workers of addiction services

by Cipriani, A., Hong, J.S.W, Lingford-Hughes, A.R, Macdonald, O., Ostacher, M.J, Ostinelli, E.G, Smith, K., Zangani, C.
Published 2022

Assessment of blinding in randomized controlled trials of antidepressants for depressive disorders 2000–2020: A systematic review and meta-analysis

by Baethge, C., Cipriani, A., Furukawa, T.A, Horinouchi, N., Ito, M., Lelliott, M., Lin, Y.-H, Sahker, E., Shinohara, K., Tomlinson, A.
Published 2022

PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depress...

by Attenburrow, M.-J, Au-Yeung, S.K, Bogacz, R., Browning, M., Chan, F., Cipriani, A., Cleare, A., Cowen, P., Edwards, C., Evans, J., Geddes, J., Griffiths, J., Harmer, C.J, Harrison, P.J, Kessler, D., Lewis, G., Rendell, J., Roberts, S., Shanyinde, M., Simon, J., Singh, I., Watson, S., Yu, L.-M
Published 2022